| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 07/27/2006 | US20060167048 N-4-piperidinyl compounds as ccr5 modulators |
| 07/27/2006 | US20060167043 Isoquinoline derivatives having kinasae inhibitory activity and drugs containing the same |
| 07/27/2006 | US20060167036 Receptor or non-receptor; 5,6,7,8,9,10-hexahydro-6,9-(epiminomethano) benzo[ alpha ][8]annulenes; anticarcinogenic, antidiabetic, antiproliferative agents; autoimmune and Crohn's diseases, acromegaly, aging resistance; coadminister tamoxifen, raloxifene, taxol, trastuzumab, tirofiban or a COX-2 inhibitor |
| 07/27/2006 | US20060167034 Novel benzonaphthyridines |
| 07/27/2006 | US20060167007 Piperazinylacylpiperidine derivatives, their preparation and therapeutic use thereof |
| 07/27/2006 | US20060167003 Probucol derivatives |
| 07/27/2006 | US20060167001 Pyridazinone-derivatives as pde4 inhibitors |
| 07/27/2006 | US20060166978 Inhibitors of IkB kinase (I Kappa B Kinase); 1-acetyl-7-bromo- beta -carboline; antiinflammatory and anticarcinogenic agent; asthma, osteoarthritis, rheumatoid arthritis, Alzheimer's disease, infections, and cardiac infarct |
| 07/27/2006 | US20060166961 Cell adhesion inhibitors |
| 07/27/2006 | US20060166940 Such as (R)-2-amino-2-methyl-4-[4-(4,4,5,5,5-pentafluoro-pentyloxy)-phenyl]-butan-1-ol hydrochloride for treatment of disorders or diseases mediated by lymphocytes, and for treating acute or chronic transplant rejection or T-cell-mediated inflammatory or autoimmune diseases |
| 07/27/2006 | US20060166927 Compounds that bind to the interferon-gamma, preparation method thereof and medicaments containing same |
| 07/27/2006 | US20060166925 Substitution derivatives of n6-benzyladenosine, methods of their preparation, their use for preparation of drugs, cosmetic preparations and growth regulators, pharmaceutical preparations, cosmetic preparations and growth regulators containing these compounds |
| 07/27/2006 | US20060166890 Non-t cell binding peptides and their uses |
| 07/27/2006 | US20060166866 Cell adhesion inhibitors |
| 07/27/2006 | US20060166863 Inhibitor and stimulator of stem cell proliferation and uses thereof |
| 07/27/2006 | US20060165718 Immunizing compositions and methods of use |
| 07/27/2006 | US20060165707 Substances |
| 07/27/2006 | US20060165706 Antibodies against CTLA4 and uses therefor |
| 07/27/2006 | US20060165693 treating a patient having cancer |
| 07/27/2006 | US20060165692 Humanized anti-CD3 specific antibodies |
| 07/27/2006 | US20060165691 Humanized anti-CD3 specific antibodies |
| 07/27/2006 | US20060165689 Compositions and methods for modulation of effects on phagocyte and lymphoid cell populations employing tirc7 |
| 07/27/2006 | US20060165688 Remedies for pemphigus containing cd40l antogonist as the active ingredient |
| 07/27/2006 | US20060165684 T-cell immune response cDNA 7 (TIRC7) antagonist; rheumatoid arthritis; comprising all three complementarity determining regions (CDRs) of the VH and all three complementarity determining regions (CDRs) of the VL variable regions; inhibiting proliferation of peripheral blood mononuclear cells |
| 07/27/2006 | US20060165678 Measuring changes in level of antigen recognizable by a monoclonal antibody or antigen binding fragment; monoclonal antibody is produced by hybridoma cell line; decreased level indicates a reduced tumor; diagnosis, cell purification |
| 07/27/2006 | US20060165675 Modulation of mesenchymal cells via iga-receptors |
| 07/27/2006 | US20060165665 Immunomodulation using altered dendritic cells |
| 07/27/2006 | CA2595157A1 Imidazole and benzimidazole derivatives useful as histamine h3 antagonists |
| 07/27/2006 | CA2594629A1 Fibrosis inhibitor for implanted organ |
| 07/27/2006 | CA2594612A1 Compositions comprising pathogen-associated molecular patterns and antigens and their use to stimulate an immune response |
| 07/27/2006 | CA2593561A1 Combining therapies targeting multiple toll-like receptors and use thereof |
| 07/27/2006 | CA2591948A1 Prodrugs of 2,4-pyrimidinediamine compounds and their uses |
| 07/26/2006 | EP1683866A2 Deletion forms of IgE-dependent histamine releasing factor having histamine-releasing activity, HRF-binding peptides and the uses thereof |
| 07/26/2006 | EP1683858A2 Viral preparations, vectors, immunogens, and vaccines |
| 07/26/2006 | EP1683799A1 3-Amino-6-aryl(or 6-heteroaryl)-4-R²-thieno[2,3-b]pyridin-2-carboxylic acid amides, pharmaceutical compositions comprising the said and their use as inhibitors of TNFalpha release |
| 07/26/2006 | EP1683520A2 Water-soluble paclitaxel produgs |
| 07/26/2006 | EP1682524A1 Novel keto-oxadiazole derivatives as cathepsin inhibitors |
| 07/26/2006 | EP1682169A1 Compositions and methods of treatment |
| 07/26/2006 | EP1682165A1 Use of interferon-tau in medicine |
| 07/26/2006 | EP1682158A1 Medicament comprising a reducing alkyl-sugar monomer for the treatment of inflammatory disorders |
| 07/26/2006 | EP1682139A1 Preparation of pharmaceutical salts of 1, 4 - bipiperidine |
| 07/26/2006 | EP1682135A1 Ccr-2 antagonist salt |
| 07/26/2006 | EP1682121A1 Use of crth2 antagonist compounds in therapy |
| 07/26/2006 | EP1682072A2 AChE ANTISENSE DEOXYOLIGONUCLEOTIDE AS AN ANTI-INFLAMMATORY AGENT |
| 07/26/2006 | EP1513839B1 3-substituted quinuclidines and their use |
| 07/26/2006 | EP1448552B1 Quinoline derivatives, process for preparing them and use for the treatment of diseases mediated by s-cd23 |
| 07/26/2006 | EP1390543B1 New polynucleotides and polypeptides of the ifnalpha-17 gene |
| 07/26/2006 | EP1381686B1 Inactivation of genes of the mep pathway |
| 07/26/2006 | EP1353687B1 Methods for obtaining inhibitors of tirc7 ligand binding and uses thereof |
| 07/26/2006 | EP1351703B1 Use of a polypeptide comprising the extracellular domains of il-20ra and il-20rb for the treatment of inflammation |
| 07/26/2006 | EP1240313B1 Homologue enzymes of human heparanase and splice variants thereof |
| 07/26/2006 | EP0967991B1 Infectious bursitis vaccine |
| 07/26/2006 | CN1809570A [1,2,4 ]triazolo [1,5-a]pyrimidin-2-ylurea derivative and use thereof |
| 07/26/2006 | CN1809531A Aminopropanol derivatives as sphingosine-1-phosphate receptor modulators |
| 07/26/2006 | CN1809373A Synthetic peptide combinations and methods of producing same |
| 07/26/2006 | CN1809370A Use of B7-H3 as an immunoregulatory agent |
| 07/26/2006 | CN1809362A Substituted 1,4-diazepines and uses thereof |
| 07/26/2006 | CN1807648A Recombinant plasmid containing effective B cell activation factor gene promotor and its preparation method and uses |
| 07/26/2006 | CN1807463A White fungus heteropolysaccharide and its extract, preparation method and uses |
| 07/26/2006 | CN1807394A Novel antihistaminic piperidine derivatives and intermediates for the preparation thereof |
| 07/26/2006 | CN1806679A Immunity-enhancing health-caring food and preparation method thereof |
| 07/26/2006 | CN1266164C Lucid ganoderma spore powder polysaccharide, production method and use |
| 07/26/2006 | CN1266149C Use of aspergillus fumigatus in preparing anti inflammatory immunosuppressant |
| 07/26/2006 | CN1266134C Fused-polycyclic compounds |
| 07/26/2006 | CN1265820C Compound solanum lyratum injection agent for animal |
| 07/26/2006 | CN1265793C Oral compound levocetirizine pseudoephedrine formulation and its preparation |
| 07/25/2006 | US7081513 Peptides having Chemotaxis Inhibitory Protein from Staphylococcus aureus (CHIPS) activity for diagnosis, prophylaxis and treatment of inflammation and HIV |
| 07/25/2006 | US7081476 Tocopherol enriched compositions for reducing IL6 levels |
| 07/25/2006 | US7081468 Angiogenesis inhibitors; antitumor agents; skin disorders; antiarthritic agents |
| 07/25/2006 | US7081459 1-substituted pyridine-2-ones or 2-substituted pyridazin-3-ones; anticarcinogenic agents for breast and prostate cancer; contraceptives; endometriosis, benign prostatic hypertophy |
| 07/25/2006 | US7081456 N-substitued-4-(3-oxo(thio)chromeno[4,3-c]pyrazol-2(3H)-yl) benzamides or N-substituted-4-(3-oxo-3,5-dihydro-pyrazolo[4,3-c]quinolin-2-yl) benzamides; CD80 antigen antagonists capable of inhibiting the interactions between CD80 and CD28 |
| 07/25/2006 | US7081351 Immobilized and labeled; detection cell differentiation, cell proliferation; prevent binding to fibroblast growth factor |
| 07/25/2006 | US7081345 For use in diagnostic, prognostic, prophylactic or therapeutic formulation |
| 07/25/2006 | US7081242 Administering conjugate comprising (a) a non-immunogenic valency platform molecule and (b) two or more molecules comprising double stranded DNA (dsDNA) epitopes, wherein the dsDNA epitopes are polynucleotides which specifically bind to an antibody from the individual |
| 07/25/2006 | CA2283663C Benzocycloheptathiophene compounds |
| 07/25/2006 | CA2159603C Quinolines as type iv phosphodiesterase inhibitors |
| 07/25/2006 | CA2159192C Immunomodulator cell adhesion inhibitor, and agent for treating and preventing autoimmune diseases |
| 07/20/2006 | WO2006076633A1 MODULATORS OF THE GLUCOCORTICOID RECEPTOR, AP-1, AND/OR NF-κB ACTIVITY AND USE THEREOF |
| 07/20/2006 | WO2006075784A1 ANTI-α9 INTEGRIN ANTIBODY AND THE USE THEREOF |
| 07/20/2006 | WO2006075668A1 STABILIZED HUMAN IgG1 AND IgG3 ANTIBODIES |
| 07/20/2006 | WO2006074919A2 3-AMINO-6-ARYL(OR 6-HETEROARYL)-THIENO[2,3-B]PYRIDIN-2-CARBOXAMIDES, PHARMACEUTICAL PREPARATIONS CONTAINING THE SAME AND THEIR USE AS TNFα INHIBITORS |
| 07/20/2006 | WO2006001965A3 Reducing the risk of human anti-human antibodies through v gene manipulation |
| 07/20/2006 | US20060161004 Quinoline derivatives for therapy and prophylaxis of chronic obstructive pulmonary disease (COPD), asthma, airway hyper-reactivity, cough, inflammatory diseases such as inflammatory bowel disease, psoriasis, fibrositis, osteoarthritis |
| 07/20/2006 | US20060160904 Adamantane derivatives, processes for their preparation and pharmaceutical composition containing them |
| 07/20/2006 | US20060160864 Acrylamide derivative, process for producing the same, and use |
| 07/20/2006 | US20060160856 Diarylurea derivatives and their use as chloride channel blockers |
| 07/20/2006 | US20060160846 Quinoline derivatives |
| 07/20/2006 | US20060160804 Novel pyridazine derivatives and medicines containing the same as effective ingredients |
| 07/20/2006 | US20060160798 3-Cyclohexyl-1-methyl-2-pyridin-2-yl-1H-indole-6-carboxylic acid methyl ester; hepatitis C virus infection; synergistic with another inhibitor of HCV polymerase or immunomodulatory agent such as interferons |
| 07/20/2006 | US20060160779 2,2-Di-substituted 1alpha,25-dihydroxy-19-norvitamin d derivative |
| 07/20/2006 | US20060160771 Aminophosphonic acid derivatives, addition salts thereof and sip receptor modulators |
| 07/20/2006 | US20060160765 Inhibitors of nucleoside phosphorylases and nucleosidases |
| 07/20/2006 | US20060160754 Glycyrrhizin high-concentration preparation |
| 07/20/2006 | US20060160726 Cyclic agonists and antagonists of C5a receptors and G protein-coupled receptors |
| 07/20/2006 | US20060160159 Identification of actinobacillus actinomycetemcomitans antigens for use in the diagnosis, treatment, and monitoring of periodontal diseases |
| 07/20/2006 | US20060160145 Assay that makes use of the interaction of early pregnancy factor (EPF) or an EPF-related peptide with a human dorsal root receptor (hDRR) or hDRR related receptor; also useful to determine whether the test compound is an agonist or antagonist of hDRRs |
| 07/20/2006 | US20060159706 Novel insertion sites in pox vectors |
| 07/20/2006 | US20060159704 Use of flavivirus for the expression of protein epitopes and development of new live attenuated vaccine virus to immunize against flavivirus and other infectious agents |
| 07/20/2006 | US20060159693 Idiotypic vaccine |
| 07/20/2006 | US20060159678 Modulators of cytokine mediated signaling pathways and integrin alphabeta3 receptor antagonists for combination therapy |